CJ Bioscience, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 18, 2026The maintenance fee for Compositions Comprising Bacterial Strains (US 10,322,151) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Jan 23, 2027The maintenance fee for Compositions comprising bacterial strains (US 10,357,520) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
- 3 fees due Feb 15 to 27, 2027 · next Feb 15
- 2 fees due Apr 10 to 29, 2027 · next Apr 10
- 1 fee due May 12, 2027The maintenance fee for Compositions Comprising Bacterial Strains (US 10,471,108) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 2 fees due Jun 3 to 10, 2027 · next Jun 3
- 1 fee due Jul 2, 2027The maintenance fee for Enterococcus gallinarum flagellin polypeptides (US 11,857,614) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Sep 10, 2027The maintenance fee for Compositions Comprising Bacterial Strains (US 10,583,158) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
- 3 fees due Oct 7 to 19, 2027 · next Oct 7
Recent changes
- 6 terms have ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,314,489 | Bacterium for use as a probiotic for nutritional and medical applications In force · From the USPTO record | In force | From the USPTO record | |
| US 10,226,489 | Composition of Bacteroides Thetaiotaomicron for Immune Modulation In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,456,444 | Pirin polypeptide and immune modulation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,973,872 | Pirin polypeptide and immune modulation In force · From the USPTO record | In force | From the USPTO record | |
| US 11,723,933 | Composition of bacteroides thetaiotaomicron for immune modulation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,322,151 | Compositions Comprising Bacterial Strains In force · High confidence | In force | High confidence | |
| US 10,391,130 | Compositions Comprising Bacterial Strains In force · High confidence | In force | High confidence | |
| US 10,493,112 | Compositions Comprising Bacterial Strains In force · High confidence | In force | High confidence | |
| US 10,500,237 | Compositions comprising bacterial strains In force · From the USPTO record | In force | From the USPTO record | |
| US 10,744,167 | Compositions Comprising Bacterial Strains In force · High confidence | In force | High confidence |
Also on record, not counted in the 22: 24 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 2 no status recorded